CCR2 and neoplasm: Concurrently, Lesokhin et al. confirmed in a B16 melanoma-bearing mouse model that chronic secretion of GM-CSF from the tumor led to recruitment of monocytic MDSCs, characterized by CCR2/CD11b co-positivity, which inhibited TIL proliferation and infiltration in the TME (29).